Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Sep 16;11(9):e5671.
doi: 10.7759/cureus.5671.

Inositol Supplementation in the Prevention of Gestational Diabetes Mellitus

Faryal Tahir  1 , Zainab Majid  1
Affiliations
Review

Inositol Supplementation in the Prevention of Gestational Diabetes Mellitus

Faryal Tahir et al. Cureus. .

Abstract

Inositol, an emerging novel therapy for the treatment of gestational diabetes mellitus (GDM), is a cyclic polyol that has insulin-like effects and plays an important role in glucose homeostasis. The conventional treatment of GDM with insulin and oral antihyperglycemic drugs usually comes with side effects, paving the way for and shedding spotlight on clinical trials involving inositol. This review analyzed a host of recent trials that involved inositol supplementation for preventing GDM and their positive outcomes in reducing the rate of GDM among obese and overweight pregnant women, as well as women with polycystic ovarian syndrome (PCOS) or a family history of type 2 diabetes mellitus.

Keywords: d-chiro-inositol; diabetes; gestational diabetes mellitus; inositol; insulin resistance; myo-inositol.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

References

    1. Nutritional supplementation for the prevention and/or treatment of gestational diabetes mellitus. Plows JF, Reynolds CM, Vickers MH, Baker PN, Stanley JL. Curr Diab Rep. 2019;19:73. - PubMed
    1. The influence of D-chiro-inositol and D-myo-inositol in pregnant women with glucose intolerance. Dell'Edera D, Sarlo F, Allegretti A, Simone F, Lupo MG, Epifania AA. Biomed Rep. 2017;7:169–172. - PMC - PubMed
    1. Long term (>1 year) postpartum glucose tolerance status among Indian women with history of gestational diabetes mellitus (GDM) diagnosed by IADPSG criteria. Goyal A, Gupta Y, Kalaivani M, et al. Diabetes Res Clin Pract. 2018;142:154–161. - PubMed
    1. Abnormal glucose tolerance post-gestational diabetes mellitus as defined by the International Association of the Diabetes and Pregnancy Study Groups criteria. Noctor E, Crowe C, Carmody LA, et al. Eur J Endocrinol. 2016;175:287–297. - PubMed
    1. Quintanilla Rodriguez BS, Mahdy H. StatPearls Publishing, LLC. Treasure Island, FL.: StatPearls [Internet]; 2019. Gestational Diabetes. - PubMed

LinkOut - more resources